Skip to content
Medical Health Aged Care

Monash Experts: National Stroke Week 2024

Monash University 4 mins read

National Stroke Week, run by the Stroke Foundation, runs from 5 – 11 August 2024, and aims to encourage the community to know the F.A.S.T. (Face, Arms, Speech and Time) signs of stroke so we can save a life in the event of a loved one experiencing a stroke.

 

Monash experts are available to discuss strokes, and the importance of awareness of the disease this week.

  • Stroke is a leading cause of death and disability in Australia
  • Women are twice as likely to die from stroke than breast cancer
  • Stroke is a serious public health issue and costs the Australian economy more than $26 billion in lost wellbeing and premature death each year
  • More than 80 per cent of strokes can be prevented
  • The impact of stroke on survivors and carers can be significant, ranging from profound limitations relating to self care, movement and communication to difficulty with balance, ongoing fatigue and loss of concentration 

Professor Monique Kilkenny, Head of Big Data, Epidemiology, and Prevention Division, Stroke and Ageing, Monash University

Contact details: [email protected] 

 

The following can be attributed to Professor Kilkenny:

 

“Around the world, a stroke occurs in every 1 in 4 people in their lifetime. Right now in Australia, there are over half a million people who have experienced a stroke. Stroke is one of the leading causes of death and disability. The number one risk factor for stroke is high blood pressure.

 

“Knowing the FAST signs of stroke, and responding promptly by calling 000, can drastically improve the outcomes for someone experiencing a stroke. This week, have a conversation with your loved ones about the signs of stroke and monitoring blood pressure – the biggest risk factor for stroke. There have been major advances over the last decade in the treatments available for patients with stroke – but reaching hospital in time remains the biggest challenge.

 

“In collaboration with the University of Tasmania and the Stroke Foundation, we are developing and testing a new digital platform, “Love Your Brain”, to educate the community about stroke. There is huge public demand for information about how to stop stroke, which can be met by our “Love Your Brain” digital platform. 

 

“National Stroke Week gives us the opportunity to be reminded about stroke and the importance of prevention and management of risk factors such as high blood pressure, high cholesterol and diabetes.”

 

Professor Dominique Cadilhac, Co-director and Research Lead of the Stroke and Ageing Group, School of Clinical Sciences, Monash University

Contact details: 0403 253 912 or [email protected]

 

The following can be attributed to Professor Cadilhac:

 

“Stroke is a catastrophic health event for individuals and families. Depending on which part of the brain is affected means the ability to think, speak, feel or move your body can be impacted. But knowing the signs of stroke and acting FAST in calling an ambulance and going to hospital is essential to avoiding life long disability or death from stroke.

 

“There have been major advances over the last decade in treating stroke with proven benefits in reducing its complications. However, as the number of survivors of stroke increases more needs to be done at the public health level to reduce the risk of stroke through primary prevention and in discovering new therapies to reduce disability or better support people and their caregivers living in the community after stroke.

 

"The Stroke and Ageing Research Group are at the forefront of research in preventing,  treating and innovating to support the long term needs of people living with stroke. 

 

“National Stroke Week gives us the opportunity to be reminded about stroke, its warning signs and symptoms, and how it remains a major health challenge in this century worldwide, including in Australia.”

 

Professor Natasha Lannin, Head of the Brain Recovery and Rehabilitation Group, Department of Neuroscience, Monash University

Contact details: 0417 135 153 or [email protected]

 

The following can be attributed to Professor Lannin:

 

“Rehabilitation is a crucial part of recovery for stroke survivors. In addition to rehabilitation treatments that are based on research evidence, it is important that Australians are given the ability to choose both the type and the timing of their rehabilitation.

 

“National Stroke Week gives us the opportunity to advocate for improved post-hospital rehabilitation across Australia, irrespective of postcode. Research to support delivery of rehabilitation using new technologies, personalised medicine and specialist hubs will see Australia tackle this challenge: delivering best-practice rehabilitation at the right time and right place.

 

"The Brain Recovery and Rehabilitation Research Group lead world-first clinical trials testing the efficacy of rehabilitation interventions, with trial experience involving both specific interventions such as movement retraining to prevent falls after stroke, as well as delivery of complex rehabilitation services, such as vocational rehabilitation to support the transition to working again after a stroke.

 

“In collaboration with international researchers from Nottingham University, our group has completed a randomised controlled trial testing the benefit of early rehabilitation targeting work and working after first stroke. Results are promising, but scaling up this complex intervention is not a straight forward task here in Australia. We are excited to have received funding from the Medical Research Futures Fund to complete an implementation trial to test this and these results are expected early 2025.”

 

For more information on National Stroke Week: https://strokefoundation.org.au/what-we-do/prevention-programs/national-stroke-week

For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or [email protected]

More from this category

  • Medical Health Aged Care, Mental Health
  • 09/03/2026
  • 00:01
University of New South Wales

UNSW Media — Study offers hope that childhood trauma doesn’t determine your future

Childhood traumadoesn’tdetermineyour future, new 12-year study shows [Sydney| 00:01 09/03/2026] New research from UNSW Sydney has found that childhood trauma does not inevitably lead to poor outcomes in adulthood—and that many people who experience adversity still thrive for decades afterwards. The 12-year study, published in American Psychologist, followed 1,668 Australian adults to investigate how adverse childhood experiences (ACEs) shape mental wellbeing across adult life. The researchersidentifiedtwo wellbeing pathways: a “resilient” group whomaintainedhigh wellbeing over time, and a “risk” group, and found two thirds of peoplemaintainedstrong mental wellbeing into adulthood despite childhood trauma. While individuals with ACEs were twice as likely…

  • Medical Health Aged Care, Women
  • 08/03/2026
  • 07:00
Monash University

What women really want re their health – and why they can’t always get it

What women really want re their health – and why they can’t always get it The most comprehensive study of the health conditions and social issues affecting women and girls in Australia has just been published by Monash University researchers and The Sisterhood Foundation. It reveals that women’s and girls’ health is often overlooked, underfunded, and misunderstood. The study found that the health system, researchers and the media mostly think about women’s health in terms of their reproductive health. However, there is a need to go ‘beyond the bikini line’ and focus on all aspects of women’s and girls’ health…

  • Medical Health Aged Care
  • 06/03/2026
  • 19:10
Claritas HealthTech Ltd

Claritas iPET(TM) Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic Goods Administration (TGA) has approved the software device, Claritas iPET™ for supply in Australia.This clearance from TGA in Australia further expands the reach and use of Claritas iPET™, already cleared and used in several jurisdictions. This software tool which is agnostic to equipment type and manufacturer, and which integrates into existing hospital…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.